| Literature DB >> 10571156 |
T Halmos1, J W Turek, G C Le Breton, K Antonakis.
Abstract
SQBAzide, a biotinylated, azido derivative of the TXA2 receptor antagonist, SQ31,491, was synthesized and characterized. The compound specifically inhibited human platelet aggregation mediated by TXA2 receptor activation and irreversibly labeled platelet TXA2 receptors upon exposure to ultraviolet light. This probe should prove to be of significant value for the study of the receptor-ligand binding domain.Entities:
Mesh:
Substances:
Year: 1999 PMID: 10571156 DOI: 10.1016/s0960-894x(99)00511-9
Source DB: PubMed Journal: Bioorg Med Chem Lett ISSN: 0960-894X Impact factor: 2.823